-+ 0.00%
-+ 0.00%
-+ 0.00%

Cartesian Therapeutics Q2 EPS $0.46 Beats $(0.86) Estimate

Benzinga·08/06/2026 11:26:11
Listen to the news
Cartesian Therapeutics (NASDAQ:RNAC) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $(0.86) by 153.49 percent. This is a 8 percent decrease over earnings of $0.50 per share from the same period last year.